A thyroid uptake scan doesn’t directly diagnose cancer, but it reveals which nodules are suspicious enough to investigate further. The scan works by measuring how much radioactive tracer your thyroid tissue absorbs. Nodules that fail to absorb the tracer, called “cold” nodules, are the ones that raise concern for malignancy. Roughly 4% to 8% of cold nodules turn out to be cancerous, depending on factors like sex and iodine intake.
How the Scan Works
Your thyroid is one of the few organs in your body that actively pulls iodine from your bloodstream. It needs iodine to manufacture thyroid hormones. Special transporter proteins on thyroid cells grab circulating iodide and bring it inside, where enzymes convert it and incorporate it into the hormones T3 and T4. A thyroid uptake scan exploits this natural process by giving you a small amount of radioactive iodine (typically iodine-123) or a similar tracer called technetium-99m. Both get absorbed by active thyroid tissue, and a gamma camera then creates an image showing where the tracer concentrated.
Healthy thyroid tissue lights up evenly. If a nodule is functioning normally or overproducing hormones, it absorbs the tracer just like surrounding tissue, or even more. But if a nodule has lost normal thyroid cell function, which can happen when cells become cancerous, it absorbs little or no tracer. That difference in absorption is what the scan reveals.
Cold, Warm, and Hot Nodules
Scan results classify nodules into three categories based on how much tracer they pick up compared to the surrounding thyroid:
- Hot nodules absorb more tracer than the surrounding tissue. They’re overproducing thyroid hormones and rarely harbor cancer. Current guidelines say these nodules don’t need a biopsy.
- Warm nodules absorb roughly the same amount as normal thyroid tissue. They carry an intermediate level of concern.
- Cold nodules absorb less tracer than the tissue around them, appearing as dark spots on the image. These are the ones most associated with malignancy.
The logic is straightforward: cancer cells often lose the specialized machinery that normal thyroid cells use to trap iodine. Without functioning transporter proteins, the cells can’t pull in the radioactive tracer, so they show up as gaps in the image.
What a Cold Nodule Actually Means
Finding a cold nodule does not mean you have cancer. Most cold nodules are benign, including cysts, areas of inflammation, or non-functioning adenomas. In a large study of over 5,600 patients with cold nodules, cancer was found in 4.2% of women and 8.2% of men. Iodine intake also plays a role: populations with sufficient dietary iodine had a cancer rate of about 5.3% in cold nodules, compared to 2.7% in iodine-deficient areas.
So while a cold nodule is the scan’s main red flag, it’s a flag for further testing, not a cancer diagnosis. The next step is almost always an ultrasound to look at the nodule’s shape, borders, and internal features. Only if the ultrasound shows suspicious characteristics will your doctor recommend a fine needle aspiration biopsy, which is the test that can actually confirm or rule out cancer by examining cells under a microscope.
Why Not Every Nodule Gets a Scan
You might assume every thyroid nodule should get a radioactive scan, but guidelines from the American Thyroid Association are specific about when to order one. The first step is a blood test measuring TSH (the hormone that controls your thyroid). If your TSH is low, suggesting your thyroid is overactive, a scan is recommended to check whether a nodule is “hot” and driving that overactivity. If your TSH is normal or high, a scan is not the recommended first imaging test. Instead, ultrasound takes priority.
This approach exists because the scan’s main strength is identifying hot nodules that can be safely left alone. For nodules in patients with normal or elevated TSH, ultrasound provides more useful detail about size, shape, and internal features that better predict malignancy risk.
What Happens During the Test
The procedure typically requires three visits over 24 hours. At the first visit, you swallow a small capsule containing the radioactive tracer. You return three to six hours later for a first uptake measurement, where a gamma camera positioned near your neck records how much tracer your thyroid has absorbed. You come back again at the 24-hour mark for a second measurement. The two readings together show how quickly and completely your thyroid is taking up iodine.
Before the scan, you may need to follow a low-iodine diet so your thyroid is “hungry” for iodine and absorbs the tracer effectively. Guidelines vary on how long: American and British guidelines suggest one to two weeks, while European guidelines recommend up to three weeks. Research has shown that as few as four days on a low-iodine diet (keeping intake below 50 micrograms per day) may be sufficient. During this period, you’ll avoid iodized salt, dairy, seafood, and processed foods with high iodine content. You’ll also need to stop certain medications that could interfere with the results, which your doctor will review with you beforehand.
Iodine-123 vs. Technetium-99m
Two tracers are commonly used. Iodine-123 is generally preferred because thyroid cells process it almost identically to natural iodine, giving a more accurate picture of true thyroid function. Technetium-99m pertechnetate is cheaper, more widely available, and produces results quickly since imaging can happen within 20 to 30 minutes rather than requiring a 24-hour return visit.
In a study of 316 patients imaged with both tracers, iodine-123 images were rated slightly higher in quality, but the difference was clinically insignificant in most cases. Discrepancies between the two tracers appeared in only 5% to 8% of cases, and none of the 12 cancers found in the study occurred in nodules where the two tracers disagreed. In practice, either tracer provides reliable information for classifying nodules as hot, warm, or cold.
What the Scan Can Miss
A thyroid uptake scan has real limitations for cancer detection. It tells you about a nodule’s function, not its cellular structure. A cold nodule could be cancer or one of several benign conditions, and the scan alone can’t distinguish between them. That’s why biopsy remains the gold standard for diagnosis.
Certain thyroid cancers are also harder to detect with this approach. Medullary thyroid cancer arises from a different cell type that doesn’t absorb iodine the way normal thyroid cells do, so these tumors will always appear cold, but for non-specific reasons. Anaplastic thyroid cancer, a rare and aggressive form, also loses the ability to concentrate iodine. Both of these cancer types require other diagnostic tools for proper identification. Even among the more common papillary and follicular thyroid cancers, which account for the vast majority of cases, the scan can only flag a nodule as suspicious. It cannot grade how advanced a cancer is or whether it has spread.
Small nodules under 1 centimeter may also be missed entirely, as the gamma camera’s resolution has limits. This is another reason ultrasound, which can detect nodules as small as 2 to 3 millimeters, plays a larger role in the initial workup for most patients.